---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-062870"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2022-05-19T23:59:59+00:00"
generated_at: "2026-06-25T09:26:24.633302+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition Corp. appoints Kyle Campbell as independent Class III director

## Summary
- Kyle Campbell appointed as Class III director effective May 16, 2022.
- Board determined Campbell is independent under Nasdaq and SEC rules; joins Audit Committee.
- Campbell is senior analyst at Greenhaven Road Capital and former CFO of a family office.
- No family relationships or transactions with the company exist.

## SEC filing metadata
- accession: 0001104659-22-062870
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2022-05-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/0001104659-22-062870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/tm2215972d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-062870
- JSON: https://secwatch.observer/filing/0001104659-22-062870.json
- Plain text: https://secwatch.observer/filing/0001104659-22-062870.txt

## Key facts
- Executive change
  Kyle Campbell was appointed as Class III director at Aspire Biopharma Holdings, Inc..
  - Action: appointed
  - Role: Class III director
  source text: Effective May 16, 2022, the board of directors (the “Board”) of PowerUp Acquisition Corp., a Cayman Islands exempted company (the “Company”), appointed Kyle Campbell, as a Class III director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/0001104659-22-062870-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.